Trial intelligence / Profile preview

Vitamin D in Children with Autonomic Nervous Mediated Syncope

NCT04844957Phase 1Unknown

Sponsor
Kongyujie
Start
May 2020
Primary completion
Dec 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of vitamin d in syncope, sponsored by Kongyujie. Primary endpoint: Vitamin D levels at 3 months. Status: unknown.

02

Drugs

vitamin d
03

Conditions

syncope

Beyond the preview

Go deeper on NCT04844957.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04844957.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call